Researchers further define nonstructural protein targets of SARS-CoV-2 The crystal structure of nonstructural protein 16 of SARS-CoV-2, which plays a role in viral RNA capping to mimic host messenger RNA, reveals specific rational design targets that could be used to develop effective therapies against SARS-CoV-2 and other coronaviruses. The research was published in Nature Communications on July 24. Discuss
Human-infecting coronaviruses have lived in bats for decades Genome sequencing of the SARS-CoV-2 virus has revealed that the type of virus family to which the novel coronavirus belongs most likely first emerged in bats in the late 1960s, according to a new study published in Nature Microbiology on July 28.
SARS-CoV-2 disguises its own genetic material to facilitate infection The SARS-CoV-2 virus is able to camouflage itself to promote viral replication, as revealed by structural details of proteins on the surface of the virus. Researchers discovered an enzyme that they believe could be an important target for antiviral drug development, according to a July 14 Nature Communications report. Discuss
Life science instrumentation market adapts to COVID-19 To reflect the new realities of the analytical instrumentation market during the COVID-19 pandemic and in the subsequent pandemic-driven recession, Strategic Directions International, a sister company of The Science Advisory Board, has released its revised edition of the Global Assessment Report. Discuss
Could COVID-19 end standoff on tests developed in laboratories? During the COVID-19 pandemic, research and clinical laboratories were working overtime to develop tests that would help them identify and understand SARS-CoV-2, according to Kalorama Information, a sister company of The Science Advisory Board. These lab-developed tests have become an essential component in the fight against the virus. Discuss